DB28906InvestigationalSmall molecule
Adermastat is a small molecule drug. Adermastat is under investigation in clinical trial NCT03858686 (The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.).
- Mechanism
- Curator reviewed
Pharmacologically active on Macrophage metalloelastase
- Also known as
- Aderamastat
- Code names
- FP-025
Resolves to
Compound
Targets
What you can answer from here — as of June 17, 2026
Which drugs share a target with Adermastat, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account